Antibiotic resistance in gonorrhea
Antibiotic resistance in gonorrhea
Antibiotic resistance in gonorrhea refers to the ability of the bacterium Neisseria gonorrhoeae to resist the effects of antibiotics that were once effective in treating infections caused by this pathogen. This resistance has become a significant public health concern globally.
Overview[edit]
Neisseria gonorrhoeae is the causative agent of gonorrhea, a common sexually transmitted infection (STI). Over the years, the bacterium has developed resistance to multiple classes of antibiotics, including penicillin, tetracycline, fluoroquinolones, and more recently, cephalosporins.
Mechanisms of Resistance[edit]
The mechanisms by which Neisseria gonorrhoeae develops antibiotic resistance include:
- **Genetic mutations**: Changes in the bacterial DNA can lead to resistance.
- **Horizontal gene transfer**: The bacterium can acquire resistance genes from other bacteria.
- **Efflux pumps**: These proteins expel antibiotics from the bacterial cell.
- **Enzymatic degradation**: The bacterium produces enzymes that inactivate antibiotics.
Current Treatment Challenges[edit]
The increasing resistance of Neisseria gonorrhoeae to antibiotics has made treatment more challenging. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have updated their treatment guidelines to recommend dual therapy with ceftriaxone and azithromycin as the first-line treatment. However, there are concerns about the emergence of strains resistant to these antibiotics as well.
Prevention and Control[edit]
Efforts to combat antibiotic resistance in gonorrhea include:
- **Surveillance**: Monitoring the spread of resistant strains.
- **Research**: Developing new antibiotics and alternative treatments.
- **Public health initiatives**: Promoting safe sex practices and regular STI screenings.
Related Pages[edit]
- Gonorrhea
- Antibiotic resistance
- Neisseria gonorrhoeae
- Sexually transmitted infection
- Centers for Disease Control and Prevention
- World Health Organization
See Also[edit]
References[edit]
External Links[edit]
| Infectious disease and microbiology | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
